Continuous Glucose Monitoring adds Information Beyond HbA1c in Well-Controlled Diabetes Patients with Early Cardiovascular Autonomic Neuropathy

Hyperglycemia as evaluated by HbA1c is a risk factor for the development of cardiovascular autonomic neuropathy (CAN). The aim of the present study was to investigate whether continuous glucose monitoring (CGM) may add information beyond HbA1c in patients with type 2 diabetes and CAN.

Source: Journal of Diabetes and Its Complications - June 30, 2017 Category: Endocrinology Authors: Jesper Fleischer, Esben Laugesen, Simon Lebech Cichosz, Pernille Hoeyem, Thomas Fremming Dejgaard, Per Loegstrup Poulsen, Lise Tarnow, Troels Krarup Hansen Source Type: research